机译:在Docetaxel时代的新诊断转移前列腺癌中生存:来自917例踩踏试验控制臂的数据(MRC PR08,CRUK / 06/019)
University of Warwick Cancer Research Unit Warwick Medical School;
Department of Urology Christie NHS Foundation Trust;
Queen Alexandra Hospital;
Hull and East Yorkshire Hospitals NHS Trust;
Mount Vernon Hospital;
University of Glasgow Beatson West of Scotland Cancer Centre;
Royal Surrey County Hospital;
Western General Hospital;
Royal Marsden NHS Foundation Trust;
Institute of Cancer Sciences University of Glasgow;
Kantonsspital Graübunden;
Department of Urology University Hospital;
Velindre Hospital;
Medical Research Council Clinical Trials Unit University College London;
Control arm cohort; Hormone-na?ve; Metastatic; Natural history; Prognostic factors; Prospective data; Prostate cancer; Survival; Time to progression;
机译:RE:在“多西紫杉醇时代”中的新诊断转移前列腺癌中生存:来自917例踩踏试验控制臂的数据(MRC PR08,CRUK / 06/019)
机译:在“多西他赛时代”中新诊断为转移性前列腺癌的患者的生存:来自STAMPEDE试验对照组的917例患者的数据(MRC PR08,CRUK / 06/019)
机译:在Docetaxel时代的新诊断转移前列腺癌中生存:来自917例踩踏试验控制臂的数据(MRC PR08,CRUK / 06/019)
机译:在新诊断的转移性前列腺癌中使用多西他赛的无可辩驳的证据:STAMPEDE和CHAARTED试验的结果
机译:在“多西他赛时代”中新诊断为转移性前列腺癌的患者的生存:来自STAMPEDE试验对照组的917例患者的数据(MRC PR08,CRUK / 06/019)